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Cutting Edge: LPS-Induced Emergency Myelopoiesis
Depends on TLR4-Expressing Nonhematopoietic Cells
Steffen Boettcher,*,†,1 Patrick Ziegler,*,‡,1 Michael A. Schmid,*,†
Hitoshi Takizawa,*,† Nico van Rooijen,x Manfred Kopf,{ Mathias Heikenwalder,‖ and
Markus G. Manz*,†
Systemic bacterial infection is rapidly recognized as
an emergency state leading to neutrophil release into
the circulation and increased myeloid cell production
within the bone marrow. However, the mechanisms of
sensing infection and subsequent translation into emer-
gency myelopoiesis have not been defined. In this study,
we demonstrate in vivo in mice that, surprisingly, selec-
tive TLR4 expression within the hematopoietic com-
partment fails to induce LPS-driven emergency myelo-
poiesis. In contrast, TLR4-expressing nonhematopoietic
cells are indispensable for LPS-induced, G-CSF–medi-
ated myelopoietic responses. Furthermore, LPS-induced
emergency myelopoiesis is independent of intact IL-
1RI signaling and, thus, does not require inflamma-
some activation. Collectively, our findings reveal a key
and nonredundant role for nonhematopoietic compart-
ment pathogen sensing that is subsequently translated
into cytokine release for enhanced, demand-adapted
myeloid cell production. The Journal of Immunology,
2012, 188: 5824–5828.
E
mergency myelopoiesis caused by systemic bacterial in-
fection is characterized by mobilization of neutrophils
from the bone marrow (BM), leading to leukocytosis
and neutrophilia. In parallel, BM granulocytic precursors in-
crease in frequency and accelerate cell cycle progression to re-
plenish mature, rapidly consumed neutrophils. These processes
are governed by the concerted action of multiple hematopoietic
growth factors (1–5). However, it is unclear how increased
hematopoietic growth factor availability and the induction of
emergency myelopoiesis upon systemic pathogen spread are
regulated.
Sensing of conserved pathogen-associated molecular pat-
terns occurs through pattern-recognition receptors, such as
TLRs (6). In addition to their expression and function on
mature hematopoietic cells, such as macrophages and den-
dritic cells, TLRs are expressed on immature hematopoietic
stem cells, as well as on myeloid (7), lymphoid (8), and den-
dritic cell (9, 10) progenitor cells, and TLR triggering on
hematopoietic stem and progenitor cells can lead to differ-
entiation into mature effector cells (11–14). Importantly, TLR
expression on some nonhematopoietic tissues, such as endo-
thelial cells and stromal cells, and their involvement in local
immune responses were also demonstrated recently (15–17).
In this study, we addressed the fundamental question of
whether sensing of Gram-negative infection-derived LPS and
subsequent acute initiation of emergency myelopoiesis depend
on TLR expression within the hematopoietic or nonhema-
topoietic cellular compartment.
Materials and Methods
Mice and generation of reciprocal chimeras
Six- to ten-week-old female wild-type (WT) B6.SJL-PtprcaPep3b/BoyJ
(CD45.1+) or C57BL/6 TLR42/2 (CD45.2+) (18) mice were lethally irra-
diated with 13 Gy and transplanted i.v. with 3–5 3 104 sorted Lin2c-Kithigh
cells of the respective, indicated genotype. All mice were maintained at the
Institute for Research in Biomedicine and University Hospital Zurich animal
facility and treated in accordance with guidelines of the Swiss Federal Vet-
erinary Office. Experiments were approved by the Dipartimento della Sanita` e
Socialita`, Ticino, Switzerland and Veterina¨ramt des Kantons Zurich, Swit-
zerland.
Treatment and analysis of mice
WT, TLR42/2, IL-1RI2/2 (19), and chimeric mice were injected twice i.p.
with 35 mg LPS (Escherichia coli 0111:B4, Ultrapure; InvivoGen, San Diego,
CA) in a 48-h interval and analyzed 24 h later. Cytospins from peripheral
blood (PB) were prepared, and May–Grunwald–Giemsa staining was per-
formed. For FACS analysis of myelopoietic responses, Gr-1 (RB6-8C5) and
CD11b (M1/70) Abs were used (both from eBioscience). Myeloerythroid
progenitor FACS analysis and CFU assays were performed, as described (7).
WT and TLR42/2 mice were injected i.p. with 250 mg/kg body weight
human G-CSF (Filgrastim; Amgen) six times in a 12-h interval and analyzed
with the same method used for the LPS-injected mice. Plasma G-CSF was
analyzed by ELISA, according to the manufacturer’s instructions (R&D
*Institute for Research in Biomedicine, 6500 Bellinzona, Switzerland; †Division of
Hematology, Zurich University Hospital, 8091 Zurich, Switzerland; ‡Hematology
and Oncology, Rheinisch-Westfaelische Technische Hochschule Aachen, 52074 Aachen,
Germany; xDepartment of Molecular Cell Biology, VU University Amsterdam, 1081 BT
Amsterdam, The Netherlands; {Institute of Integrative Biology, Molecular Biomedicine,
Swiss Federal Institute of Technology Zurich, 8952 Schlieren, Switzerland; and ‖Insti-
tute for Virology, Technische Universita¨t Mu¨nchen/Helmholtz Center Mu¨nchen, 81675
Munich, Germany
1S.B. and P.Z. contributed equally to this work.
Received for publication November 15, 2011. Accepted for publication April 18, 2012.
This work was supported in part by the Helmholtz Foundation, the Swiss National
Science Foundation and a starting European Research Council grant (to M.H.), the
German Academic Exchange Service (D/06/44442 to S.B.), the Swiss National Science
Foundation (310000-116637), Oncosuisse (OCS-02019-02-2007), and the Bill and
Melinda Gates Foundation Grand Challenges in Global Health initiative (to M.G.M.).
Address correspondence and reprint requests to Prof. Markus G. Manz, Division of
Hematology, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzer-
land. E-mail address: markus.manz@usz.ch
The online version of this article contains supplemental material.
Abbreviations used in this article: BM, bone marrow; PB, peripheral blood; WT, wild-
type.
Copyright 2012 by TheAmerican Association of Immunologists, Inc. 0022-1767/12/$16.00
www.jimmunol.org/cgi/doi/10.4049/jimmunol.1103253
Systems). For macrophage depletion, mice received 400 ml liposomal clodr-
onate i.p. (provided by N.v.R) twice in a 48-h interval (for experimental
details see Supplemental Fig. 2E).
Tissue macrophage isolation and analysis
Single-cell suspensions from BM and spleen were prepared and subjected to
digestion with collagenase D (0.25%; Roche Diagnostics) and DNAse I (20 U/
ml; Roche Diagnostics). Hepatic macrophages were isolated, as previously
reported (20). Peritoneal macrophages were isolated by repeatedly instilling
and aspirating 10 ml warm PBS into the peritoneal cavity. FcRs were blocked
using purified CD16/32 (93) Ab and stained with Pacific blue-conjugated
CD45.1 (A20), FITC-conjugated CD45.2 (104), PE-conjugated F4/80
(BM8), and allophycocyanin-conjugated CD11b (M1/70) Abs (all from
eBioscience) to determine donor/recipient chimerism.
Lung tissues were embedded in Tissue-Tek OCT compound (Sakura),
frozen in liquid nitrogen, and stored at 280˚C. Five-micron-thick cry-
osections were cut on a Leica CM 1950 Cryostat (Leica) and fixed in acetone.
The following Abs were used: CD45.1-Alexa Fluor 488 (A20), CD45.2-
allophycocyanin (104) (both from eBioscience), and CD68 (Serotec) com-
FIGURE 1. PB neutrophilia and BM emergency myelopoiesis are exclusively dependent on TLR4-expressing nonhematopoietic cells in vivo but do not require
intact IL-1R signaling. (A) May–Grunwald–Giemsa staining of cytospin preparations of PB from WT, TLR42/2, and chimeric mice at 72 h after double PBS
injection (top panel) or LPS (35 mg from E. coli strain 0111:B4) injection (bottom panel). Original magnification 3250. (B) Percentages of CD11b+Gr-1+ mature
and immature myeloid cells in PB of PBS- or LPS-injected WT, TLR42/2, and chimeric mice, as described in (A). Mean 6 SEM of two independent
experiments, with a total of three PBS- and four LPS-treated mice/group, are shown. (C) Representative FACS profile of CD11b+Gr-1high and CD11b+Gr-1low
cells in the BM of WT, TLR42/2, and chimeric mice after PBS or LPS injection, as described in (A). Percentages of CD11b+Gr-1high mature (D) and
CD11b+Gr-1low immature (E) myeloid cells in the BM of PBS- or LPS-treated WT, TLR42/2, and chimeric mice after LPS stimulation. Mean 6 SEM of five
independent experiments, with a total of 5 PBS- and 10 LPS-treated mice/group, are shown. (F) Representative FACS profile of CD11b+Gr-1high and
CD11b+Gr-1low cells in the BM of WT and IL-1RI2/2 mice after PBS or LPS injection, as described in (A). (G) Percentages of CD11b+Gr-1+ mature and
immature myeloid cells in PB from PBS- or LPS-injected WT and IL-1RI2/2 mice, as described in (A). Mean 6 SEM of three independent experiments, with
a total of five PBS- and eight LPS-treated mice/group, are shown. Percentages of CD11b+Gr-1high mature (H) and CD11b+Gr-1low immature (I) myeloid cells in
the BM of PBS- or LPS-treated WT and IL-1RI2/2 mice after LPS stimulation. Mean 6 SEM of three independent experiments, with a total of five PBS- and
eight LPS-treated mice/group, are shown. *p , 0.05, **p , 0.01, ***p , 0.001.
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bined with a secondary goat anti-rat–Alexa Fluor 594 Ab (Invitrogen).
Immunoselect mounting medium (DAPI; Dianova) was used for embedding
stained cryosections. Images were acquired on a Leica SP5 confocal micro-
scope (Leica) and analyzed using Leica LAS AF Lite 2.4 software. Para-
formaldehyde-fixed and paraffin-embedded liver sections were analyzed
using F4/80 mAb (BM8).
Equations and statistical analyses
Significance of differences was analyzed with an ungrouped or grouped two-
tailed Student t test or one-sample t test, where appropriate. All statistical
analyses were calculated with GraphPad Software, v5.01 (Prism).
Results and Discussion
We generated BM chimeric mice with TLR42/2 hematopoiesis
on a WT nonhematopoietic background (TLR42/2/WT
mice) and WT hematopoiesis on a TLR42/2 nonhemato-
poietic background (WT/TLR42/2 mice). At 12 wk after
transplantation, no differences in engraftment efficiency or
lineage reconstitution were observed, and residual host CD45+
BM chimerism was ,1% (data not shown, Supplemental Fig.
1A). Remaining host cells consisted mostly of long-lived
CD3+ T cells (Supplemental Fig. 1B). Importantly, the vast
majority (.97%) of tissue-resident macrophages in BM,
spleen, lung, and peritoneal cavity were of donor origin 3 mo
after transplantation (Supplemental Fig. 1C, 1D). However,
∼20% of hepatic macrophages were still host derived, con-
sistent with previous findings (20). Chimeric and control mice
were challenged with LPS or PBS and analyzed for the first
hallmark of emergency myelopoiesis: induction of neutrophilia
and increase in myeloid precursors in the PB. No differences
between nonreconstituted (WT and TLR42/2) and control-
reconstituted (WT/WT and TLR42/2/TLR42/2) control
mice were observed (data not shown). There was an increase
in mature and immature neutrophils in the PB of WT and
TLR42/2/WT mice, as revealed by morphological exami-
nation of cytospin preparations and by immunophenotypical
analysis using CD11b and Gr-1 Ags. In contrast, TLR42/2
and WT/TLR42/2 mice failed to mount a respective re-
sponse to systemic LPS challenge (Fig. 1A, 1B, Supplemental
Fig. 1E).
FIGURE 2. G-CSF is strongly increased upon selective stimulation of TLR4-expressing nonhematopoietic cells and is a major mediator of emergency
myelopoiesis in vivo. (A) Plasma G-CSF protein levels in PBS- or LPS-treated (35 mg from E. coli strain 0111:B4) WT, TLR42/2, and chimeric mice analyzed
72 h after double injection. Mean6 SEM of three independent experiments, each with three PBS- and four LPS-treated mice/group, are shown. (B) Plasma G-CSF
protein levels in PBS- or LPS-treated IL-1RI2/2 mice, treated as described in (A). Mean 6 SEM of two independent experiments, with a total of three PBS- and
six LPS-treated mice/group, are shown. (C) Representative FACS profile showing myeloid cells (CD11b+Gr-1+) in PB of G-CSF–treated WT mice and TLR42/2
mice. The treatment regimen consisted of six injections with 250 mg human G-CSF/kg body weight every 12 h over a period of 3 d. Mice were analyzed 24 h after
the last injection. (D) Representative FACS profile of CD11b+Gr-1high and CD11b+Gr-1low cells in the BM of WT and TLR42/2 mice following G-CSF
injection, as described in (C). (E) Percentages of CD11b+Gr-1+ mature and immature myeloid cells in PB from PBS- or G-CSF–injected WT and TLR42/2mice,
as described in (C). Mean 6 SEM of two independent experiments, with a total of four G-CSF–treated mice, are shown. Percentages of CD11b+Gr-1high mature
(F) and CD11b+Gr-1low immature (G) myeloid cells in the BM of PBS- or G-CSF–injected WT and TLR42/2 mice, as described in (C). Mean 6 SEM of two
independent experiments, with a total of four G-CSF–treated mice, are shown. **p , 0.01, ***p , 0.001, ****p , 0.0001.
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Next, we studied the second hallmark of emergency mye-
lopoiesis: BM myeloid proliferation and differentiation. In
WT and TLR42/2/WT mice, mature myeloid cells
(CD11b+Gr-1high) decreased significantly upon LPS injection,
whereas the frequency and total numbers of immature pro-
myelocytes and myelocytes (CD11b+Gr-1low) (21, 22) in-
creased up to 2.5-fold (Fig. 1C–E, data not shown). In
contrast, no change in cellular composition could be observed
in TLR42/2 or WT/TLR42/2 mice, whereas a small, but
still significant relative, but not absolute, increase in immature
CD11b+Gr-1low cells was detectable in WT/TLR42/2 mice
(Fig. 1E, data not shown). Because granulocyte-macrophage
progenitors and CFU-granulocyte increased in WT and
both TLR42/2/WT and WT/TLR42/2 mice, signaling
through TLR4 in hematopoietic and nonhematopoietic cells
can skew early hematopoiesis toward myeloid differentiation
(Supplemental Fig. 2A–C). However, nonhematopoietic cell-
expressed TLR4 is sufficient, as well as necessary, for induc-
tion of full-blown emergency myelopoiesis.
IL-1b is a paradigmatic proinflammatory cytokine driving
the expression of various myelopoiesis-acting cytokines, such
as G-csf, M-csf, and Gm-csf (23). Thus, initiation of emergency
myelopoiesis may involve activation of the inflammasome,
leading to IL-1b release that stimulates IL-1RI–expressing cells
to secrete myelopoiesis-acting growth factors, which, in turn,
promote emergency myelopoiesis, as suggested recently (24).
However, LPS stimulation caused an identical emergency
myelopoietic response in IL-1RI2/2 mice compared with WT
mice (Fig. 1F–I, data not shown). Thus, we conclude that
IL-1RI signaling may be involved in alternative pathways
leading to reactive neutrophilia, such as treatment with the
adjuvant alum (22, 24). However, our findings unambiguously
show that LPS-induced emergency myelopoiesis does not re-
quire intact IL-1RI signaling, a clinically important finding
with respect to current anti–IL-1–directed therapies (25).
We next sought to determine the mediating signal, which
is released upon LPS-induced TLR4 signaling in nonhema-
topoietic cells. To this end, we focused on the key myeloid
cytokine G-CSF. Although G-CSF is not indispensable for
emergency myelopoiesis, G-CSF2/2 mice show markedly re-
duced and delayed kinetics of neutrophilia (26, 27). Moreover,
G-CSF is successfully applied to treat congenital or chemo-
therapy-induced neutropenia (1) and, most importantly, is
highly increased in patient serum during bacterial-induced
inflammation or sepsis (28, 29). In accordance with these
clinical findings, a significant ∼10-fold increase in plasma
G-CSF levels was observed after LPS injection in WT and
TLR42/2/WT mice, whereas no significant increase was
detectable in WT/TLR42/2 mice (Fig. 2A). An identical
increase in G-CSF plasma levels was observed in IL-1RI2/2
mice (Fig. 2B). The minor, nonsignificant increase in G-CSF
in WT/TLR42/2 mice might be responsible for the small
relative increase in immature BM CD11b+Gr-1low cells in
these mice (Fig. 1E) and is possibly mediated via hemato-
poietic cell (i.e., progenitor cell or myeloid cell) LPS sensing.
However, it is insufficient to generate a sustained myelopoietic
response. We also assessed plasma levels of M-CSF, GM-CSF,
SCF, IL-3, and FLT3L. Of these, only FLT3L levels increased
significantly, specifically in WT and WT/TLR42/2 mice,
indicating a primarily hematopoietic cell-mediated induction
or origin upon LPS stimulation (data not shown).
To determine whether the massive increase in G-CSF upon
LPS stimulation is, as a single cytokine, sufficient to translate
into emergency myelopoiesis, we injected human G-CSF into
WT and TLR42/2mice. This treatment led to qualitative and
quantitative responses that were indistinguishable from those
induced by LPS application (Fig. 2C–G, data not shown).
Thus, our data reveal that the primary, indispensable in vivo
sensing site for LPS-induced emergency myelopoiesis is a
TLR4-expressing nonhematopoietic cellular compartment that
translates this signal into massive G-CSF release. We reason
that the few remaining primarily hepatic macrophages do not
play a major role in this context, because macrophage-depleted
mice show a similar myeloid response as do control mice
(Supplemental Fig. 2D–H). Future studies are needed to
clarify the identity and localization of the TLR4-expressing
and, likely cytokine-releasing, nonhematopoietic parenchy-
mal or stromal cell populations. Selective delivery of TLR
mimetics to these cells could then be an intriguing therapeutic
possibility to enhance myeloid cell regeneration, supplement-
ing the current need for application of single recombinant
cytokines.
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